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Individualized Catheter Surveillance among Neonates: 
A Prospective, 8-Year, Single-Center Experience 
Walter Zingg, MD; Klara M. Posfay-Barbe, MD; Riccardo E. Pfister, MD; 
Sylvie Touveneau, RN; Didier Pittet, MD, MS 
OBJECTIVE. To monitor trends in central line-associated bloodstream infections and clinical sepsis (CLABICS) among neonates and to 
determine risk factors for infection, especially dwell time. 
DESIGN. Prospective, single-center cohort study conducted from 2001 through 2008. 
SETTING. University-affiliated tertiary care center. 
METHODS. Individualized surveillance of catheter use and CLABICS episodes was conducted. Data were obtained via regular on-site 
visits made 3 times a week. Trends over time were estimated by Poisson regression, and risk factor analysis was conducted using a Cox 
proportional hazards model and logistic regression. 
RESULTS. In all, 1,124 neonates were exposed to 2,210 central lines for a total of 12,746 catheter-days and 11,467 catheter-days at risk. 
The median duration of catheter use was 8 (interquartile range, 5-11) days for peripherally inserted central catheters (PICCs) and 4 
(interquartile range, 2-6) days for umbilical catheters; 102 CLABICS episodes were detected. The median time to infection was 7 days. 
Incidence densities were 8.5 CLABICS episodes per 1,000 catheter-days at risk and 8.0 CLABICS episodes per 1,000 catheter-days. The 
highest rates were identified among neonates weighing 750 g or lower (14.9 CLABICS episodes per 1,000 catheter days at risk) and for 
PICCs (13.2 CLABICS episodes per 1,000 catheter days at risk). Catheter dwell time was associated with CLABICS for all umbilical catheters 
(odds ratio [OR], 1.2 per day of use [95% confidence interval {CI}, 1.1-1.3]; P< .001) and for PICCs for up to 7 days (OR, 1.2 [95% CI, 
1.1-1.4]; P = .041), but not thereafter (OR, 1.0 [95% CI, 0.9-1.1]; P = .90). 
CONCLUSION. Catheter dwell time is a risk factor for CLABICS during the first 7 days, irrespective of catheter type. After 7 days, PICCs 
are less likely to become infected. 
Infect Control Hosp Epidemiol 2010; 32(l):42-49 
Healthcare-associated infections (HAIs) are the leading pre- umbilical catheters, and to place our findings in the context 
ventable adverse events in critically ill patients and are as- of the available literature, 
sociated with considerable morbidity, mortality, and use of 
additional resources.1,2 Neonates, particularly preterm infants M E T H O D S 
with a very low birth weight or extremely low birth weight, 
are at high risk for HAIs, with reported rates ranging from ° 
6 to 9 episodes per 1,000 patient-days.3"5 In contrast to adults, A prospective cohort study was conducted from April 1,2001, 
among whom the proportion of bloodstream infections and through December 31, 2008, at the University of Geneva 
sepsis is only approximately 5%-8%,6 8 in neonates blood- Hospitals (Geneva, Switzerland), a 2,100-bed university-af-
stream infections may represent up to three-quarters of all filiated primary and tertiary care center that has a 20-bed 
HAIs.9"18 neonatal intensive care unit (NICU) and an 8-bed pediatric 
The objectives of the present study were to assess secular intensive care unit (PICU). Neonates were hospitalized in the 
trends for central line-associated bloodstream infections and PICU if they needed ventilation. In 2001, we established an 
clinical sepsis (CLABICS), to determine risk factors for CLA- ongoing, prospective HAI surveillance program for neo-
BICS in peripherally inserted central catheters (PICCs) and nates.19 All neonates with a central line (PICC or umbilical 
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TABLE l. Catheter Dwell Times Stratified by Birth Weight Category among Neonates—University 
of Geneva Hospitals, 2001-2008 
Birth weight category 
s$750 g 
751-1,000 g 
1,001-1,500 g 
1,501-2,500 g 
> 2,500 g 
Trend2 
P value 
All catheters 
Mean (SD) 
dwell time, days 
8.2 (5.9) 
7.0 (5.0) 
6.1 (3.9) 
4.7 (3.1) 
4.1 (3.2) 
-4.4% 
<.001 
Median (IQR) 
dwell time, days 
7 (4-11) 
6(4-9) 
5 (3-8) 
4 (3-6) 
3 (2-5) 
Umbilical catheters 
Mean (SD) 
dwell time, days 
5.8 (3.7) 
4.5 (2.2) 
4.3 (2.8) 
3.8 (2.2) 
3.6 (2.0) 
-4.5% 
<.001 
Median (IQR) 
dwell time, days 
5 (3-8) 
4 (3-6) 
4 (2-6) 
4 (2-5) 
3 (2-5) 
NOTE. IQR, interquartile range; SD, standard deviation. 
* Mean change in dwell time per birth weight category. 
catheter) were prospectively included in the study; there was 
no exclusion criterion for neonates with a central line. 
Surveillance 
The same infection control nurse visited the NICU and PICU 
3 times a week for on-site surveillance during the entire study 
period.19 Each neonate included in the study was prospectively 
monitored, and data on such variables as birth weight, Clin-
ical Risk Index for Babies (CRIB) score, Apgar score, and 
gestational age were collected.20,21 Each PICC, umbilical artery 
catheter, and umbilical venous catheter was monitored in-
dividually during the entire life span of the device. Neonates 
with long-term tunneled central venous catheters were ex-
cluded from the study. HAIs were identified via medical rec-
ord review, an automated alert system for positive blood cul-
ture results, participation by the infection control nurse in 
ward rounds, direct information from physicians and nursing 
staff, direct observation of neonates, and complete review of 
laboratory reports.19,22 
Definitions 
The occurrence of CLABICS, defined as laboratory-confirmed 
bloodstream infection or clinical sepsis, was the primary end 
point. Clinical sepsis was included as an outcome parameter 
because blood culture samples from neonates are often not 
reliable, and thus ignoring clinical sepsis would underestimate 
the true rate of bloodstream infection.22"24 CLABICS episodes 
were defined according to the US Centers for Disease Control 
and Prevention (CDC) criteria.25,26 All infections were con-
firmed by a neonatologist (R.E.P.) or an infectious diseases 
and infection control physician (K.M.P.-B. or W.Z.). A CLA-
BICS episode was considered to be associated with health care 
if diagnosed 3 days or more after birth. Dwell time was de-
fined as the number of full days a catheter was in place. 
Statistical Analysis 
Crude analysis was conducted by analyzing CLABICS epi-
sodes on the basis of the total number of catheter-days or 
patient-days, respectively.27 For risk analysis, only the first 
CLABICS episodes were considered; they were analyzed on 
the basis of the number of catheter-days or patient-days at 
risk. At-risk days were defined as catheter-days or patient-
days before a CLABICS episode. Subsequent days and sub-
sequent catheters were excluded from the analysis. Exposure 
to parenteral nutrition and antibiotics was included in the 
risk analysis if present before a CLABICS episode. Continuous 
variables were summarized as means and medians and were 
compared by the Student t test or the Wilcoxon rank sum 
test, as appropriate. A Cox proportional hazards model was 
used to investigate the association between the time at risk 
of developing CLABICS and various variables, such as birth 
weight, gestational age, parenteral nutrition, antibiotic use, 
and CRIB score. We modeled time to event in a single-event 
analysis in which the unit of analysis was the catheter. Because 
a neonate could have more than 1 catheter either at the same 
time or sequentially, we adjusted for intragroup correlation 
by specifying each neonate as a cluster.28,29 We first investi-
TABLE 2. Pathogens Isolated from Central Line-Associated Blood-
stream Infections among Neonates—University of Geneva Hospitals, 
2001-2008 
Pathogen 
Staphylococcus epidermidis 
Other coagulase-negative staphylococci 
Staphylococcus capitis 
Escherichia coli 
Enterococcus species 
Methicillin-susceptible Staphyloccocus 
aureus 
Methicillin-resistant S. aureus 
Streptococcus viridans 
Enterobacter cloacae 
Klebsiella pneumoniae 
Frequency 
(n = 69) 
30 (43.5) 
17 (24.6) 
6 (8.7) 
6 (8.7) 
4 (5.8) 
2 (2.9) 
1 (1.5) 
1 (1.5) 
1 (1.5) 
1 (1.5) 
NOTE. Data are no. (%) of pathogens. Thirty-three infections were clinical 
sepsis episodes. 
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TABLE 3. Incidence Densities (IDs) for Central Line-Associated Blood-
stream Infections and Clinical Sepsis (CLABICS) among Neonates, Overall 
and by Birth Weight and Catheter Type—University of Geneva Hospitals, 
2001-2008 
Category 
Patient-days 
Patient-days at risk 
Catheter-days 
Catheter-days at risk 
Birth weight category 
^750 g 
751-1,000 g 
1,001-1,500 g 
1,501-2,500 g 
>2,500 g 
Catheter type 
PICCs 
UACs 
UVCs 
Birth weight category 
<750g 
751-1,000 g 
1,001-1,500 g 
1,501-2,500 g 
>2,500 g 
Catheter type 
PICCs 
UACs 
UVCs 
No. of 
CLABICS episodes 
102 
97 
102 
97 
CLABICS episoc 
28 
34 
30 
7 
3 
80 
3 
19 
CLABICS episodes ] 
25 
33 
29 
7 
3 
75 
3 
19 
Days of 
exposure 
Overall 
46,173 
24,048 
12,764 
11,467 
ID (95% CI) 
2.2 (1.8-2.7) 
4.0 (3.3-4.9) 
8.0 (6.5-9.7) 
8.5 (6.9-10.3) 
es per 1,000 catheter-days 
2,062 
2,700 
3,916 
2,169 
1,917 
6,909 
1,528 
4,327 
13.6 (9.0-19.6) 
12.6 (8.7-17.6) 
7.7 (5.2-10.9) 
3.2 (1.3-6.6) 
1.6 (0.3^.6) 
11.6 (9.2-14.4) 
2.0 (0.4-5.7) 
4.4 (2.6-6.8) 
aer 1,000 catheter-days at risk 
1,681 
2,215 
3,583 
2,095 
1,893 
5,664 
1,508 
4,295 
14.9 (9.6-21.9) 
14.9 (10.3-20.9) 
8.1 (5.4-11.6) 
3.3 (1.3-6.9) 
1.6 (0.3-4.6) 
13.2 (10.4-16.6) 
2.0 (0.4-5.8) 
4.4 (2.7-6.9) 
NOTE. CI, confidence interval; PICCs, peripherally inserted central catheters; 
UACs, umbilical artery catheters; UVCs, umbilical venous catheters. 
gated all potential risk factors by univariate analysis. Variables 
with a P value of less than .02 were included in the multi-
variate analysis. P values less than .05 were considered to 
indicate statistical significance, and only variables meeting 
this criterion were retained in the final model. Time trends 
were estimated by Poisson regression. Logistic regression 
analysis was used to quantify the association with catheter 
dwell time (measured as the number of catheter-days with a 
CLABICS episode) and to distinguish between catheter types 
related to such a risk. Similar to the strategy for the Cox 
proportional hazards model, we adjusted for intragroup cor-
relation by specifying each neonate as a cluster, and integra-
tion of variables in the multivariate analysis was done ac-
cordingly. All statistical analyses were conducted with Stata 
software, version 10.0 (StataCorp). 
RESULTS 
Patient Characteristics 
From 2001 through 2008, 3,772 neonates were hospitalized, 
totaling 46,173 patient-days. Of these neonates, 1,124 (30%) 
had 1 or more central vascular access devices and were in-
cluded in the study. The median gestational age of the ne-
onates was 32 (interquartile range [IQR], 29-37) weeks. Most 
neonates were singletons (894 [80%]); 492 (44%) had a very 
low birth weight, and 205 (18%) had an extremely low birth 
weight. Mean and median CRIB scores were 3.3 (standard 
deviation [SD], 3.8) and 2 (IQR, 1-5), respectively. Mean and 
median birth weights were 1,943 (SD, 1,012) and 1,660 (IQR, 
1,130-2,730) g, respectively. The median Apgar score after 5 
minutes was 9 (IQR, 7-9). The total length of stay was 29,646 
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FIGURE I. Time to infection for peripherally inserted central catheters and umbilical catheters among neonates-
Hospitals, 2001-2008. 
-University of Geneva 
days, with a mean of 26.6 (SD, 27.2) days and a median of 
17 (IQR, 8-37) days, respectively. A total of 24,048 days 
(81%) were patient-days at risk. There were significant trends 
over time toward lower birth weights (P < .001) but also to-
ward a shorter length of stay (P = .001). 
Central Lines 
A total of 2,210 central lines accounting for 12,764 catheter-
days were observed among the 1,124 neonates (utilization 
rate, 27.6% [12,764 of 46,173]). A total of 2,116 catheters 
(723 PICCs [34.2%], 385 umbilical artery catheters [18.2%], 
and 1,008 umbilical venous catheters [47.6%]) accounting 
for 11,467 catheter-days at risk were included in the risk 
analysis. The mean and median dwell times at risk were 7.8 
(SD, 4.7) and 8 (IQR, 5-11) days for PICCs, 3.9 (SD, 2.5) 
and 3 (IQR, 2-5) days for umbilical artery catheters, and 4.3 
(SD, 2.5) and 4 (IQR, 2-6) days for umbilical venous cath-
eters, respectively. Dwell times differed significandy between 
PICCs and umbilical catheters (median, 7 [IQR, 5-10] vs 4 
[IQR, 2-5] days; P<.001). Catheter dwell times depended 
significantly on birth weight categories (Table 1). Neonates 
weighing 750 g or less had PICCs in place twice as long as 
neonates weighing more than 2,500 g. Similarly, umbilical 
dwell times were also significantly shorter among neonates 
in the highest birth weight category than the lowest (median, 
3 [IQR, 2-5] vs 5 [IQR, 3-8] days; P< .001). Parenteral nu-
trition and intravenous antibiotics were applied through 
1,115 (53%) and 1,341 (61%) catheters, respectively. During 
the time at risk, 1,034 catheters (49%) were used for par-
enteral nutrition, and 1,205 (57%) were used for antibiotic 
therapy. 
CLABICS 
A total of 102 CLABICS episodes were observed (laboratory-
confirmed bloodstream infections, 69; clinical sepsis episodes, 
33). Most isolated pathogens (77%) were coagulase-negative 
TABLE 4. Risk Factors for Central Line-Associated Bloodstream Infections and 
Clinical Sepsis among Neonates—University of Geneva Hospitals, 2001-2008 
Variable 
Catheter type1'b 
Extremely low birth weightb 
Pluriparityb 
Apgar scoreb 
CRIB score 
Calendar year 
Parenteral nutritionb 
Antibiotic usebc 
Univariate analysis 
HR (95% CI) 
0.75 (0.56-1.01) 
2.11 (1.40-3.19) 
1.67 (1.10-2.55) 
0.99 (0.99-0.99) 
1.02 (0.98-1.07) 
0.97 (0.89-1.05) 
2.92 (1.46-5.82) 
0.39 (0.26-0.58) 
P 
.063 
<.001 
.016 
.003 
.359 
.462 
.002 
<.001 
Multivariate analysis 
HR (95% CI) P 
2.24 (1.42-3.53) .001 
2.23 (1.10-4.55) .027 
0.33 (0.21-0.52) <001 
NOTE. CI, confidence interval; CRIB, Clinical Risk Index for Babies; HR, hazard ratio. 
* Umbilical catheters vs peripherally inserted central catheters. 
b
 Included in the multivariate analysis. 
c
 Intravenous antibiotic use at any time over the central line. 
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TABLE 5. Benchmarking of Bloodstream Infections and Clinical Sepsis among Neonates at the University of 
Geneva Hospitals with the German Hospital Infection Surveillance System (KISS) and the US National Healthcare 
Safety Network (NHSN) 
Category 
Birth weight 
<1,000 g 
1,000-1,499 g 
All 
Birth weight 
<750g 
751-1,000 g 
1,001-1,500 g 
1,501-2,500 g 
>2,500 g 
All 
Birth weight 
<750g 
751-1,000 g 
1,001-1,500 g 
1,501-2,500 g 
>2,500 g 
All 
No. of 
CLABICS 
episodes 
61 
30 
91 
19 
31 
24 
5 
1 
80 
9 
3 
6 
2 
2 
22 
Geneva data 
No. of 
No. of 
CLABICS 
catheter-days ID (95% CI) episodes 
4,569 
3,993 
8,562 
1,248 
1,772 
2,447 
930 
512 
6,909 
814 
928 
1,469 
1,239 
1,405 
5,855 
Geneva data vs KISS data" 
13.4 (10.2-17.1) 661 
7.5 (5.1-10.7) 170 
10.6 (8.6-13.0) 831 
Comparison 
No. of 
catheter-days 
52,467 
22,277 
74,744 
Geneva data vs NHSN data,b central lines 
15.2 (9.1-23.7) 225 
17.5 (11.9-24.7) 185 
9.8 (6.3-14.6) 144 
5.4 (1.7-12.5) 105 
2.0 (0.0-10.8) 87 
11.6 (9.2-14.4) 746 
60,850 
55,445 
55,874 
44,402 
42,611 
259,182 
Geneva data vs NHSN data,b umbilical lines 
11.1 (5.1-21.0) 79 
3.2 (0.7-9.4) 39 
4.1 (1.5-8.9) 32 
1.6 (0.2-5.8) 15 
1.4 (0.2-5.1) 22 
3.8 (2.4-5.7) 187 
16,762 
15,034 
16,681 
16,321 
22,978 
87,776 
data 
ID (95% CI) 
12.6 (11.7-13.6) 
7.6 (6.5-8.9) 
11.1 (10.4-11.9) 
3.7 (3.2-4.2) 
3.3 (2.9-3.9) 
2.6 (2.2-3.0) 
2.4 (1.9-2.9) 
2.0 (1.6-2.5) 
2.9 (2.7-3.1) 
4.7 (3.7-5.9) 
2.6 (1.8-3.5) 
1.9 (1.3-2.7) 
0.9 (0.5-1.5) 
1.0 (0.6-1.4) 
2.1 (1.8-2.5) 
NOTE. Incidence densities (IDs) are reported as the no. of central line-associated bloodstream infections and clinical sepsis 
(CLABICS) episodes per 1,000 catheter-days. CI, confidence interval. 
• Pooled mean data from KISS. 
b
 Pooled mean data from NHSN. 
staphylococci, of which Staphylococcus epidermidis was iden-
tified the most frequently (Table 2). The overall incidence 
densities for CLABICS were 8.0 episodes per 1,000 catheter-
days and 8.5 episodes per 1,000 catheter-days at risk (Table 
3). The incidence densities for laboratory-confirmed central 
line-associated bloodstream infection with and without cases 
of clinical sepsis were 8.0 episodes per 1,000 catheter-days 
and 5.4 episodes per 1,000 catheter-days, respectively. No 
statistically significant trend in CLABICS rates over the total 
study period was observed. Of note, the observed incidence 
of infection depended largely on the denominator chosen to 
calculate it (Table 3). The incidence density varied according 
to birth weight and catheter type; neonates with a low birth 
weight and/or a PICC rather than an umbilical line had higher 
CLABICS rates (Table 3). 
The median time to a CLABICS episode for PICCs and 
umbilical catheters was 7 (IQR, 5-10) and 7 (IQR, 5-8) days, 
respectively (Figure 1). Time to infection diminished signif-
icantly over the course of the study, by a mean of 5.4% per 
year (from 9.9 [SD, 5.1] days in 2001 to 7.1 [SD, 3.1] days 
in 2008; P< .001). The time from admission to infection also 
diminished significantly, by a mean of 5.0% per year (from 
15.5 [SD, 10.0] days in 2001 to 9.9 [SD, 4.1] days in 2008; 
P< .001). As shown in Figure 1, time-to-infection curves are 
identical for PICCs and umbilical catheters, assuming that 
dwell time is a similar risk factor for both catheter types. 
Risk Factors 
The occurrence of CLABICS among all catheter types was 
independently associated with extremely low birth weight 
(P = .001) and exposure to total parenteral nutrition {P = 
.027) (Table 4). A significant reduction in the number of 
CLABICS episodes was observed when antibiotics were ad-
ministered through the catheter (P<.001). Catheter dwell 
time expressed as adjusted risk per catheter-day was signifi-
cantly associated with CLABICS in the logistic regression 
analysis (odds ratio [OR], 1.1 per day of use [95% confidence 
interval {CI}, 1.0-1.1]; P = .005). Adjustments were made 
for extremely low birth weight, exposure to parenteral nu-
trition, and antibiotic therapy. For umbilical catheters, the 
adjusted risk was significant for all catheters (OR, 1.2 per day 
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of use [95% CI, 1.1-1.3]; P< .001). However, for PICCs the 
adjusted risk was significant for a dwell time of up to 7 days 
(OR, 1.2 per day of use [95% CI, 1.1-1.4]; P = .041), but 
not thereafter (OR, 1.0 per day of use [95% CI, 0.9-1.1]; 
P = .90). 
DISCUSSION 
This single-center prospective cohort study includes data re-
corded at the individual patient level for 8 years and is the 
largest and longest of its kind, to the best of our knowledge. 
The study reveals statistically significant reductions in catheter 
dwell times over the years, confirms the importance of known 
risk factors for CLABICS (such as low birth weight and par-
enteral nutrition30"32), and highlights the unanticipated finding 
that for PICCs dwell time is statistically significanuy associated 
with CLABICS during the first 7 days, but not thereafter. 
Although prolonged catheter dwell time among neonates 
has been repeatedly associated with CLABICS,33"35 a recent 
study even found an opposite trend for PICCs.36 Our data 
do not completely contradict these data but add another per-
spective to the findings: whereas there was a statistically sig-
nificant association between dwell time and CLABICS for 
umbilical catheters, such an association was significant for 
PICCs for only up to 7 days of dwell time. The median time 
to infection was identical for umbilical catheters and PICCs. 
Because the dwell time of only 10% of umbilical catheters 
exceeded 7 days, it is no surprise that the dwell time for this 
catheter type as a whole was associated with CLABICS, 
whereas for PICCs overall no such association was observed. 
Our data show that longer dwell times for PICCs are asso-
ciated with either antibiotic therapy (OR, 1.1 [95% CI, 1.1-
1.2]; P< .001) or parenteral nutrition (OR, 1.2 [95% CI, 1.1-
1.3 ]; P < .001). Given that longer catheterization is more likely 
to be associated with antibiotic use (P< .001), which in turn 
is associated with fewer CLABICS episodes, it is no surprise 
that the incidence density for CLABICS was lower among 
PICCs with a longer duration (>7 days). However, our data 
support the hypothesis that the daily risk for CLABICS 
changes with dwell time, being highest within 7 days of place-
ment but decreasing thereafter. This is most likely due to the 
indications for PICC use in this context, especially the use 
of antibiotics. Our data suggest that the routine replacement 
of PICCs is not advisable. Although we found increased daily 
risk during the first days of placement, our results are in line 
with those of a study by Smith et al36 that found no association 
at all. However, more information is needed before any firm 
recommendation can be made, and future studies should also 
compare PICCs with peripheral catheters to verify whether 
PICCs may be replaced by peripheral lines. 
Only a few studies have reported data on time to in-
fection.37'38 Ben Jaballah et al38 found a mean of 6.6 (SD, 2.8) 
days to infection for all catheter types; Hoang et al37 reported 
a median time of 9 days for PICCs of the upper extremities, 
although the median time was longer (15 days) for PICCs of 
the lower extremities. Our findings are consistent with these 
data. Importantly, we observed that time to infection was 
similar among all catheter types. The decrease in time to 
infection in our population, however, is worrying. Prolonged 
time to infection has been shown to be a favorable indicator 
for good catheter care.28 Thus, observing the opposite trend 
may indicate that issues regarding the quality of catheter care 
exist in our NICU. Of note, prolonged time to infection could 
also be associated with the observed changes in case mix. 
A key obstacle of HAI reporting is the varying modes of 
outcome definition and denominator selection. Using the ex-
ample of ventilator-associated pneumonia, Eggimann et al27 
showed that the method of reporting pneumonia rates has a 
significant effect on risk estimates. The incidence density dou-
bled when rates were adjusted by ventilator-days at risk in-
stead of patient-days in intensive care. Our study data are 
even more pronounced: the difference between incidence 
densities expressed per 1,000 patient-days compared with 
1,000 catheter-days at risk was 4-fold. However, the difference 
between rates determined on the basis of device-days and 
device-days at risk was not pronounced. Not only does the 
denominator influence risk estimates, but the numerator— 
and hence the definition of the outcome variable—may have 
a similar effect among neonates. Including laboratory-con-
firmed bloodstream infections exclusively in a surveillance or 
adding cases with clinical sepsis results in considerable dif-
ferences in rates. The sensitivity of blood culture in neonates 
is low, and the CDC definitions of clinical sepsis leave room 
for interpretation. Considering only laboratory-confirmed 
bacteremia is likely to underestimate the true rate, whereas 
including clinical sepsis in the surveillance program is likely 
to overestimate the rate.23"26 Thus, the true rate probably can-
not be determined until more specific markers of neonatal 
bloodstream infections become available. At a time of public 
reporting of nosocomial infections, hospitals are tempted to 
report only laboratory-confirmed infections. However, given 
the low sensitivity of blood cultures in neonates, such re-
porting may underestimate central line-associated blood-
stream infection rates unacceptably, as was also evidenced by 
our study. 
Studies and HAI surveillance programs conducted among 
neonates use different formats for data reporting. The US 
National Healthcare Safety Network (NHSN) reports labo-
ratory-confirmed bloodstream infections and clinical sepsis 
and stratifies data into 5 birth weight categories, whereas the 
German Hospital Infection Surveillance System (KISS) strat-
ifies into 2 birth weight categories.39,40 Furthermore, the US 
NHSN distinguishes central from umbilical catheters in its lat-
est report.39 Such differences make comparisons and bench-
marking difficult, if not impossible. Basically, a center has to 
decide which surveillance method to use and whether bench-
marking with US or European data is preferred. Our detailed 
and individualized data collection is quite unique and allowed 
us to compare our data with both the US NHSN and German 
KISS reports (Table 5). As is shown, our CLABICS incidence 
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densities were similar to the German KISS data (10.6 [95% CI, 
8.6-12.0] vs 11.1 [95% CI, 10.4-11.9] episodes per 1,000 cath-
eter-days). However, our rates were consistently higher for cen-
tral lines, for umbilical lines, and across all birth weight cat-
egories other than 2,500 g or higher when compared with the 
NHSN (Table 5). There is no explanation for why European 
rates are so much higher than US rates, but it is noteworthy 
that not all recent US studies have produced data that are in 
line with the current (and rather low) NHSN data,39 and data 
from these studies mirror our results.36,37 
A limitation of our study is the lack of data on peripheral 
lines. Although no evidence to suggest that PICC use increases 
the risk of adverse events relative to peripheral lines was 
found,41 it would have been useful to consider our data in 
the context of all vascular access devices, and more infor-
mation on whether peripheral lines could replace PICCs is 
needed. 
In conclusion, the present study has shown that catheter 
dwell time is a risk factor for CLABICS in neonates with 
umbilical catheters and PICCs during the first 7 days of their 
use, but not thereafter. Considering the median dwell time 
of 7 days, routine PICC replacement is not advisable, in light 
of our findings. However, a firm recommendation about the 
dwell time of PICCs in neonates needs confirmation by ad-
ditional studies. Individualized catheter surveillance allows 
benchmarking with different surveillance systems and detec-
tion of unanticipated risk factors. Such detailed results on 
catheter type provide optimal feedback and enable tailor-
ing of prevention measures that account for specific local 
shortcomings. 
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